Prophylaxis in surgery : There has been much debate over the choice of
antibiotics duration of treatment and routes of administration for an
tibiotic prophylaxis in surgery patients. Several new strategies have
been proposed on the basis of pharmacological features; early experien
ce has been reported. New strategies in orthopedics : local injection
of 750 mg cefuroxime in the limb undergoing surgery has resulted in lo
cal concentrations reaching up to 133 to 88 mg/kg in bone and fat tiss
ues respectively, ie. much higher levels than those achieved by system
ic injection. In prostheses, the use of acrylic material incorporating
antibiotics such as vancomycin may prevent staphylococcal infection;
other antibiotic classes, quinolones, aminoglycosides (tobramycin in c
ombination with vancomycin) have also been used successfully Metallic
implants coated with antibiotic, for instance fluoroquinolones, have p
revented the first stage of bacterial colonization in orthopedic surge
ry by inhibiting bacterial adhesion on foreign material, as was confir
med in in vitro and in vivo experiments. Cardiovascular surgery : Ther
e has been a tendency to replace second generation cephalosporins by v
ancomycin. This offers a spectrum and pharmacokinetics which fit bette
r with the risk of staphylococcal infections with a single dose of 10
to 20 mg/kg, results have been more favorable with vancomycin. Digesti
ve surgery : A recent fluoroquinolone, trovafloxacin, with a spectrum
including anaerobes, is a useful antibiotic for prophylaxis in colorec
tal surgery, but other quinolones could be effective in other surgical
situations with an advantage in terms of cost. Improved prevention :
These recent updates in antibiotic prophylaxis strategies have shown t
hat new procedures and new strategies may contribute to improvement in
the prevention of surgical infections.